Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

Conditions: Obesity; Diabetes Mellitus, Type 2; Endocrine System Diseases; Glucose Metabolism Disorders; Metabolic Diseases
Sponsors: University of Pittsburgh; Harvard University; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 14, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments